TJ Kelley, L al-Nakkash and ML Drumm
Department of Pediatrics, Willard Bernbaum Cystic Fibrosis Center, USA.

Chloride channel activity of cystic fibrosis transmembrane conductance regulator (CFTR) requires activation of protein kinase A (PKA) by 3'-5'- cyclic adenosine monophosphate (cAMP). The level of cAMP is controlled by the balance between cAMP synthesis and hydrolysis by adenylate cyclase and phosphodiesterases (PDEs), respectively. CFTR channel activity appears to be most sensitive to the activity of type III cyclic nucleotide PDEs in Calu-3 and 16HBE cells, both derived from airway epithelium and expressing wild-type CFTR. Type III PDEs can be identified by their sensitivity to specific inhibitors such as milrinone and amrinone. In Calu-3 cells, specific inhibition of type III PDEs increased chloride efflux up to 13.7-fold, whereas neither rolipram nor Ro20-1724 (type IV PDE inhibitors) nor 3-isobutyl-1- methylxanthine (IBMX, a nonspecific PDE inhibitor) elicited significant increases. None of these compounds had an appreciable effect on total cellular cAMP levels, yet the effects of milrinone and amrinone on chloride efflux were blocked by treatment of cells with Rp-cAMPS, a cAMP analog that inhibits PKA at the site of cAMP binding. Similarly, H- 8, an inhibitor of PKA, reduced milrinone-stimulated chloride efflux, indicating that efflux is mediated through the cAMP/PKA pathway. Whole- cell patch clamp analysis revealed that milrinone generated chloride conductances with properties consistent with those of CFTR. Milrinone elicited chloride currents in a dose-dependent manner and induced CFTR activity in the absence of adenylate cyclase agonists. These data suggest that type III PDEs are specifically involved in CFTR activation in airway epithelial cells and that PDE regulation of CFTR may involve subcellular compartments of cAMP.

This article has been cited by other articles:

				J. F. Poschet, G. S. Timmins, J. L. Taylor-Cousar, W. Ornatowski, J. Fazio, E. Perkett, K. R. Wilson, H. D. Yu, H. R. de Jonge, and V. Deretic Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L712 - L719. [Abstract] [Full Text] [PDF]

				S. Liu, A. Veilleux, L. Zhang, A. Young, E. Kwok, F. Laliberte, C. Chung, M. R. Tota, D. Dube, R. W. Friesen, et al. Dynamic Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Type 3 and Type 4D Phosphodiesterase Inhibitors J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 846 - 854. [Abstract] [Full Text] [PDF]

				A. P. Barnes, G. Livera, P. Huang, C. Sun, W. K. O'Neal, M. Conti, M. J. Stutts, and S. L. Milgram Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium J. Biol. Chem., March 4, 2005; 280(9): 7997 - 8003. [Abstract] [Full Text] [PDF]

				B. R. Cobb, L. Fan, T. E. Kovacs, E. J. Sorscher, and J. P. Clancy Adenosine Receptors and Phosphodiesterase Inhibitors Stimulate Cl- Secretion in Calu-3 Cells Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 410 - 418. [Abstract] [Full Text] [PDF]

				S. Saksena, R. K. Gill, I. A. Syed, S. Tyagi, W. A. Alrefai, K. Ramaswamy, and P. K. Dudeja Modulation of Cl-/OH- exchange activity in Caco-2 cells by nitric oxide Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G626 - G633. [Abstract] [Full Text] [PDF]

				J. J. Haddad, S. C. Land, W. O. Tarnow-Mordi, M. Zembala, D. Kowalczyk, and R. Lauterbach Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. I. Differential Regulation of Lipopolysaccharide-Mediated Proinflammatory Cytokine (Interleukin-6 and Tumor Necrosis Factor-alpha ) Biosynthesis in Alveolar Epithelial Cells J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 559 - 566. [Abstract] [Full Text] [PDF]

				B. R. Cobb, F. Ruiz, C. M. King, J. Fortenberry, H. Greer, T. Kovacs, E. J. Sorscher, and J. P. Clancy A2 adenosine receptors regulate CFTR through PKA and PLA2 Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L12 - L25. [Abstract] [Full Text] [PDF]

				L. V. J. Galietta, S. Jayaraman, and A. S. Verkman Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1734 - C1742. [Abstract] [Full Text] [PDF]

				L. Al-Nakkash and P. S. Reinach Activation of a CFTR-Mediated Chloride Current in a Rabbit Corneal Epithelial Cell Line Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2364 - 2370. [Abstract] [Full Text] [PDF]

				H.C. Rodgers and A.J. Knox Pharmacological treatment of the biochemical defect in cystic fibrosis airways Eur. Respir. J., June 1, 2001; 17(6): 1314 - 1321. [Abstract] [Full Text] [PDF]

				S. G. Aller, I. D. Lombardo, S. Bhanot, and J. N. Forrest Jr. Cloning, characterization, and functional expression of a CNP receptor regulating CFTR in the shark rectal gland Am J Physiol Cell Physiol, February 1, 1999; 276(2): C442 - C449. [Abstract] [Full Text] [PDF]

				S. N. Smith, P. G. Middleton, S. Chadwick, A. Jaffe, K. A. Bush, S. Rolleston, R. Farley, S. J. Delaney, B. Wainwright, D. M. Geddes, et al. The In Vivo Effects of Milrinone on the Airways of Cystic Fibrosis Mice and Human Subjects Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 129 - 134. [Abstract] [Full Text]

				B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF]

				B. Illek, H. Fischer, and T. E. Machen II. Regulation of CFTR by small molecules including HCO-3 Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1221 - G1226. [Abstract] [Full Text] [PDF]

				Z. He, S. Raman, Y. Guo, and W. W. Reenstra Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms Am J Physiol Cell Physiol, October 1, 1998; 275(4): C958 - C966. [Abstract] [Full Text] [PDF]

				T. J. Kelley, C. U. Cotton, and M. L. Drumm Regulation of amiloride-sensitive sodium absorption in murine airway epithelium by C-type natriuretic peptide Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L990 - L996. [Abstract] [Full Text] [PDF]

				N. Darvish and J. T. Russell Neurotransmitter-Induced Novel Modulation of a Nonselective Cation Channel by a cAMP-Dependent Mechanism in Rat Pineal Cells J Neurophysiol, May 1, 1998; 79(5): 2546 - 2556. [Abstract] [Full Text] [PDF]

				T. J. Kelley, C. U. Cotton, and M. L. Drumm In vivo activation of CFTR-dependent chloride transport in murine airway epithelium by CNP Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L1065 - L1072. [Abstract] [Full Text] [PDF]

				T. J. Kelley, K. Thomas, L. J. H. Milgram, and M. L. Drumm In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant Delta F508 in murine nasal epithelium PNAS, March 18, 1997; 94(6): 2604 - 2608. [Abstract] [Full Text] [PDF]

				T. J. TORPHY Phosphodiesterase Isozymes . Molecular Targets for Novel Antiasthma Agents Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 351 - 370. [Full Text]